title: Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis?
authors.forename: H S
authors.initials: HS
authors.lastname: Thomsen
authors.forename: P
authors.initials: P
authors.lastname: Marckmann
authors.forename: V B
authors.initials: VB
authors.lastname: Logager
mesh_terms: D000075202:Contraindications; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D019786:Gadolinium DTPA / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D007674:Kidney Diseases / Q000139:chemically induced / Q000150:complications*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D012307:Risk Factors; D012595:Scleroderma, Systemic / Q000139:chemically induced*; D014057:Tomography, X-Ray Computed / Q000379:methods*
chemical_list: D003287:Contrast Media; C064925:gadodiamide; D019786:Gadolinium DTPA